Market news: South Korean court issued an arrest warrant to Seoul police chief.Contemporary Amperex Technology Co., Limited traded 175,000 shares today with a turnover of 44,625,200 yuan, while Contemporary Amperex Technology Co., Limited traded 175,000 shares today with a turnover of 44,625,200 yuan, accounting for 0.58% of the total turnover of the day. The average transaction price was 255 yuan, which was 4.51% lower than the market closing price of 267.03 yuan, of which the highest transaction price was 267.03 yuan and the lowest transaction price was 218.97 yuan.Xinxiangwei: Shareholder Xinyu Yijiade intends to reduce its shareholding by no more than 1%. Xinxiangwei announced that as of the disclosure date, Shareholder Xinyu Yijiade holds 20,175,800 shares of the company, accounting for 4.39% of the company's total share capital. Xinyu Yijiade plans to reduce the number of shares of the company by no more than 4,595,300 shares through centralized bidding or block trading of Shanghai Stock Exchange within 90 days after 15 trading days from the date of announcement, and the proportion of reduced shares in the company's total share capital is no more than 1%.
Spot silver fell more than 1.00% in the day and is now reported at $30.63 per ounce.BMO raised the target price of Chevron from $170 to $175.France's new Prime Minister Bayrou: I know my task is arduous, and we need to unite the people. Everyone knows that this road will be long.
Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.News before the US stock market, ① The three major stock index futures of the US stock market rose together, and crude oil futures rose by more than 1%. Today, the US import/export price index for November was announced. ② As of press time, Dow futures rose 0.26%, S&P 500 futures rose 0.36%, and Nasdaq futures rose 0.73%. (3) Germany's DAX index rose by 0.47%, Britain's FTSE 100 index rose by 0.15%, France's CAC40 index rose by 0.38% and Europe's Stoxx 50 index rose by 0.46%. ④WTI crude oil rose 1.19% to 70.85 USD/barrel. Brent crude oil rose 1.16% to $74.26/barrel. ⑤ Societe Generale warned that the recession index of 75-year winning streak indicates that the United States may be in recession. Behind the record high of American stock market, there is a trend that worries Wall Street strategists: fewer and fewer stocks support the stock market. ⑦ Xpeng Motors fell more than 3.5% before trading and was downgraded to "sell" by UBS. ⑧ Broadcom rose about 14% before the market, and the company's Q4 profit exceeded expectations. Pet-name ruby ZTO Express rose more than 1% before trading, and the average monthly express business volume in China reached 14 billion pieces.Senior EU officials: The foreign ministers of 27 EU countries will approve the 15th round of sanctions against Russia and new sanctions "against hybrid operations" on December 16th.
Strategy guide 12-14
Strategy guide
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14